Exercise therapy program for cancer patients
Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients
This study is testing a new exercise program for cancer patients to see if it helps them recover better by connecting their treatment with local fitness services.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital Heidelberg Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 7 sites (Freiburg im Breisgau, Baden-Wurttemberg and 6 other locations) |
| Trial ID | NCT06185777 on ClinicalTrials.gov |
What this trial studies
MOVE-ONKO is focused on creating and implementing a multi-professional care pathway that promotes exercise therapy for cancer patients. This initiative aims to connect oncological care with local exercise therapy services, ensuring that patients have access to quality exercise programs tailored to their needs and side effects. The project will be developed in phases, starting with guideline creation and followed by implementation at seven Comprehensive Cancer Centers in Germany. The ultimate goal is to integrate exercise therapy into standard cancer care, enhancing patient support and recovery.
Who should consider this trial
Good fit: Ideal candidates for this program are cancer patients undergoing chemotherapy, immunotherapy, or radiotherapy who experience symptoms that can be alleviated through exercise.
Not a fit: Patients who do not speak German or have been employed in their care provider role for less than six months may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the quality of life and recovery outcomes for cancer patients through tailored exercise therapy.
How similar studies have performed: Other studies have shown positive outcomes with exercise therapy for cancer patients, indicating that this approach is both promising and supported by existing evidence.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria (patients): * cancer patients during chemotherapy, immune therapy or radiotherapy * having symptoms/side effects that can be effectively treated by exercise (e.g. fatigue) and/or are interested in exercise oncology counseling Inclusion Criteria (care providers) \- involved in the implementation process Exclusion Criteria (both): \- Insufficient German language skills Exclusion Criteria (care providers only): \- Duration employed \<6 months
Where this trial is running
Freiburg im Breisgau, Baden-Wurttemberg and 6 other locations
- Universitätsklinikum Freiburg — Freiburg im Breisgau, Baden-Wurttemberg, Germany (Recruiting)
- Nationales Centrum für Tumorerkrankungen — Heidelberg, Baden-Wurttemberg, Germany (Recruiting)
- Medizinische Klinik der Universitätsklinikum Tübingen — Tübingen, Baden-Wurttemberg, Germany (Recruiting)
- Universitäres Centrum für Tumorekrankungen Frankfurt — Frankfurt am Main, Hesse, Germany (Recruiting)
- Universitäres Centrum für Tumorerkrankungen Mainz — Mainz, Rhineland-Palatinate, Germany (Recruiting)
- Nationales Centrum für Tumorerkrankungen Dresden (NCT/UCC) — Dresden, Saxony, Germany (Recruiting)
- Charité - Universitätsmedizin Berlin — Berlin, State of Berlin, Germany (Recruiting)
Study contacts
- Study coordinator: Joachim Wiskemann, Prof
- Email: joachim.wiskemann@nct-heidelberg.de
- Phone: +49 6221 565904
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.